Super User

Super User

Friday, 26 September 2014 00:00

FOTIVAX TM

Inactivated Foot and Mouth Disease Vaccine

COMPOSITION

FOTIVAX TM is a Foot and Mouth Disease vaccine preparation containing chemically inactivated, tissue culture derived FMD virus strains. We produce strains A, O, C, SAT1 and SAT 2. The usual blend of FOTIVAXTM contains FMD strains A, O, SAT1 and SAT2 which have been adjuvanted with Aluminium hydroxide gel and saponin. Other components of the final blend include antifoam, phenol red dye, lactalbumin hydrolysate, tryptose phosphate broth, antibiotics, amino acids, vitamins and buffer salts. Each batch undergoes potency tests in live cattle to ensure that each dose contains at least 6.6 PD 50.

PROPERTIES

Foot and Mouth Disease is the most contagious disease of animals and has a potential of causing heavy loss in susceptible cloven-hoofed animals. There are seven serotypes of FMD virus, namely, O, A, C, SAT1, SAT2, SAT3 and Asia 1. Infection with one serotype does not confer immunity against another.
Typical cases of FMD are characterised by a vesicular condition of the feet, buccal mucosa and, in females, the mammary glands. Clinical signs can vary from mild to severe and fatalities may occur, especially in young animals. All the above FMD serotypes produce identical clinical signs, yet immunity to Foot and Mouth disease is serotype-specific. Vaccination against each serotype occurring in a region is therefore indicated for protection.

INDICATIONS

For the vaccination of healthy cattle, pigs, sheep and goats as an aid in prevention and control of Foot and Mouth Disease caused by the serotypes A, O, SAT 1 and SAT2.

DOSAGE AND ADMINISTRATION

Shake well before use. Vaccination should be done using sterile needle and syringe to avoid contamination. Administer to animals of all ages via subcutaneous injection at the rate of 3mls per animal for cattle and 2mls per animal in pigs, sheep, and goats. Revaccination should be carried out every 6 months or for better protection every 4 months.

CONTRA-INDICATIONS, WARNINGS

For Veterinary use only. Do not use if seal is broken or package is damaged. Do not vaccinate un-healthy animals. All vaccines may occasionally cause anaphylactic reactions in some animals. If this occurs adrenaline should be administered.

STORAGE

Store at +4°C (Refrigerator). DO NOT FREEZE. If stored at between +2°C +8°C (refrigerator) the shelf life is one year. Once the vaccine bottle has been broached it must be used immediately and any remaining quantity discarded.

PRESENTATION

50-, 100-, and 300-ml vials.

Friday, 26 September 2014 00:00

LUMPIVAX TM:

Live Attenuated Lumpy Skin Disease Virus Vaccine

COMPOSITION

LUMPIVAXTM is a freeze-dried, live attenuated Lumpy skin disease viral vaccine prepared from the Neethling strain of the virus. The diluent is used to re-hydrate the freeze-dried component.

PROPERTIES

Lumpy skin disease is a poxvirus disease of cattle characterised by fever, nodules on the skin and mucous membranes of internal organs, emaciation, enlarged lymph nodes, oedema of the skin, and sometimes death. The disease is of economic importance because it causes reduced production, particularly in dairy herds, and damage to the hide. LSD is caused by strains of capripox virus that are antigenically indistinguishable from strains causing sheep and goat pox. However the cattle strains of capripox do not infect and transmit between sheep and goats as shown by the different geographical distribution between LSD and sheep / goat pox. Transmission of Lumpy Skin Disease is predominantly by insects and until 1988 the disease was confined to sub-Saharan Africa but then it spread into Egypt.

INDICATIONS

For the active immunization of healthy cattle against Lumpy skin disease.

DOSAGE AND ADMINISTRATION

Reconstitute each vial with the corresponding sterile diluent. Keep the reconstituted vaccine cool and protected from sunlight. Take reasonable aseptic precautions in reconstituting and withdrawing the vaccine. Administer via the subcutaneous route at the pre-scapular region to animals of all ages at the rate of 2ml per animal. Annual revaccination is recommended.

CONTRA-INDICATIONS, WARNINGS

For Veterinary use only. Do not use if seal is broken or package is damaged. Do not vaccinate un-healthy animals. Avoid contact between sheep and vaccinated cattle for at least three weeks after vaccination. All vaccines may occasionally cause anaphylactic reactions in some animals. If this occurs adrenaline should be administered.

STORAGE

Store at -20°C. (Freezer). Under these conditions, the shelf life is 2 years. If stored at between +2°C and +8°C (refrigerator) the shelf life is one month. Once the vaccine has been reconstituted, it must be used immediately and any remaining quantity discarded.

PRESENTATION

50-, 100-, and 150-dose vials packed together with the corresponding diluents

Friday, 26 September 2014 00:00

POXVAX TM

Live Attenuated Fowl Pox Virus Vaccine

COMPOSITION

POXVAX TM is a freeze-dried live attenuated Fowl pox viral vaccine prepared Fowl pox virus.The diluent is used to re-hydrate the freeze-dried component.

PROPERTIES

Fowl pox is a disease of chicken caused by a DNA virus of the genus Avipoxvirus of the family Poxviridae. Its distribution is worldwide. It is slow-spreading and characterised by the formation of proliferative lesions and scabs on the skin, and diphtheritic lesions in the upper parts of the digestive and respiratory tracts. The cutaneous form (dry pox) has a low mortality with affected birds more likely to recover as compared to the diphtheritic form (wet pox) where the proliferative lesions involving the nasal passages, larynx or trachea can result in respiratory distress and death from suffocation. Fowl pox causes transient drop in egg production, and a reduced growth rate in young birds.
POXVAX TM is prepared from modified live Fowl pox virus and induces a strong immune response against Fowl pox such that even birds incubating the disease will receive some benefit from use of the vaccine.

INDICATIONS

For the active immunization of healthy poultry against Fowl pox.

DOSAGE AND ADMINISTRATION

POXVAX TM is administered via the wing stab route using two hypodermic needles. Reconstitute the whole vial of 100-dose freeze-dried vaccine using the provided 1 ml diluent. Dip the sterilized needles into the reconstituted vaccine and stab through the wing web above the elbow joint. Birds may be vaccinated at any time after the age of 4 weeks, but it is important to ensure that vaccination is carried out before the birds come into lay. Vaccination confers immunity for one year.

CONTRA-INDICATIONS, WARNINGS

For Veterinary use only. For use in poultry only. Do not vaccinate un-healthy birds. Do not use if seal is broken or package is damaged.

STORAGE

Store at -20°C. (Freezer). Under these conditions, the shelf life is 2 years. If stored at between +2°C and +8°C (refrigerator) the shelf life is one month. Once the vaccine has been reconstituted, it must be used immediately and any remaining quantity discarded.

PRESENTATION

100-dose vials packed together with the diluent.

Friday, 26 September 2014 00:00

S&G VAX TM

Live Attenuated Sheep and Goat pox Virus Vaccine

COMPOSITION

S&G VAX TM is a freeze-dried live attenuated Sheep and goat pox viral vaccine prepared from the 0240 Kenya sheep and goat pox strain of the capripox virus. The diluent is used to re-hydrate the freeze-dried component.

PROPERTIES

Sheep pox and goat pox are viral diseases of sheep and goats characterised by fever, generalised papules or nodules, vesicles (rarely), internal lesions (particularly in the lungs), and death. Both diseases are caused by strains of capripoxvirus, all of which can infect sheep and goats.

S&G VAX TM is prepared from the 0240 Kenya sheep and goat pox strain of the capripoxvirus.

INDICATIONS

For the active immunisation of healthy sheep and goats against sheep pox and goat pox.

DOSAGE AND ADMINISTRATION

Reconstitute each vial with the corresponding sterile diluent. Keep the reconstituted vaccine cool and protected from sunlight. Take reasonable aseptic precautions in reconstituting and withdrawing the vaccine. Administer via the subcutaneous route at the rate of 1ml per animal. Goats and sheep over 5 weeks of age only should be vaccinated, however in the face of an outbreak , animals as young as 3 weeks old may be vaccinated. Annual revaccination is recommended.

CONTRA-INDICATIONS, WARNINGS

For Veterinary use only. Do not use if seal is broken or package is damaged. Do not vaccinate un-healthy animals. All vaccines may occasionally cause anaphylactic reactions in some animals. If this occurs adrenaline should be administered. This preparation is for use in sheep and goats only.

STORAGE

Store at -20°C. (Freezer). Under these conditions, the shelf life is 2 years. If stored at between +2°C and +8°C (refrigerator) the shelf life is one month. Once the vaccine has been reconstituted, it must be used immediately and any remaining quantity discarded.

PRESENTATION

50-, 100-, and 150-dose vials packed together with the corresponding diluent. 

Friday, 26 September 2014 00:00

TURKEYVAX TM

Live Attenuated Turkey Pox Virus Vaccine

COMPOSITION

TURKEYVAXTM is a freeze-dried live attenuated Turkey pox viral vaccine prepared Turkey pox virus.The diluent is used to re-hydrate the freeze-dried component.

PROPERTIES

Turkey pox is a disease of Turkeys caused by a DNA virus of the genus Avipoxvirus of the family Poxviridae. Its distribution is worldwide. It is slow-spreading and characterised by the formation of proliferative lesions and scabs on the skin, and diphtheritic lesions in the upper parts of the digestive and respiratory tracts. The cutaneous form (dry pox) has a low mortality with affected birds more likely to recover as compared to the diphtheritic form (wet pox) where the proliferative lesions involving the nasal passages, larynx or trachea can result in respiratory distress and death from suffocation. Turkey pox causes transient drop in egg production, and a reduced growth rate in young birds. TURKEYVAX TM is prepared from modified live Turkey pox virus and induces a strong immune response against Turkey pox such that even birds incubating the disease will receive some benefit from use of the vaccine.

INDICATIONS

For the active immunisation of healthy Turkeys against Turkey pox.

DOSAGE AND ADMINISTRATION

TURKEYVAX TM is administered via the wing stab route using two hypodermic needles. Reconstitute the whole vial of 100-dose freeze-dried vaccine using the provided 1 ml diluent. Dip the sterilized needles into the reconstituted vaccine and stab through the wing web above the elbow joint. Birds may be vaccinated at any time after the age of 4 weeks, but it is important to ensure that vaccination is carried out before the birds come into lay. Immunity develops within 14 days of vaccination and lasts for one year.

CONTRA-INDICATIONS, WARNINGS

For Veterinary use only. For use in Turkeys only. Do not vaccinate un-healthy birds. o not use if seal is broken or package is damaged.

STORAGE

Store at -20°C. (Freezer). Under these conditions, the shelf life is 2 years. If stored at between +2°C and +8°C (refrigerator) the shelf life is one month. Once the vaccine has been reconstituted, it must be used immediately and any remaining quantity discarded.

PRESENTATION

100-dose vials packed together with the diluent.

Wednesday, 24 September 2014 00:00

Management Team

Ø  Abdi Adan Suleiman - Ag. Chairman

Ø  Ms. Asli Halake Fayo – Member

Ø  Mr. Sospeter Nyongesa - Member

Ø  Mr. Aden Abdulla Hussein - Member

Ø  Mr. Isacko Galgalo Mamo - Member

Ø  Dr. Joseph Litamoi - Member

Ø  Mr. Dida Jaldesa - Member

Ø  Mr. Bernard Saidimu - Member

Ø  Principal Secretary - National Treasury Alternate: Mr. Paul Kiagu

Ø  Principal Secretary - State Department of Livestock MOALF Alternate: Mr. William Koech Director Kari Alternate:

Dr. L.W. Wamae

Wednesday, 24 September 2014 00:00

Our Core Values

In conducting its functions, the Institute will uphold the following guiding principles:

Ø  Loyalty

Ø  Honesty

Ø  Team work and commitment

Ø  Professionalism

Ø  Innovativeness

Ø  Integrity, Accountability and transparency

Ø  Partnerships

Corporate Social Responsibility

Wednesday, 24 September 2014 00:00

Our Core Function

The Institute is expected to deliver on the following:

Ø  Co-ordinate and take charge of all veterinary vaccines production in the country.

Ø  Research, either alone or in collaboration with other research institutions, into new innovations of veterinary vaccines production.

Ø  Develop and produce chemicals, media and laboratory products for use in the production of vaccines and other veterinary products.

Ø  Market and distribute veterinary vaccines locally and abroad.

Provide information in the field in other activities as the Board with the approval of the President may determine.

Wednesday, 24 September 2014 00:00

Mission, Vision and Mandate

Our Mission

To produce safe, efficacious and affordable veterinary vaccines through undertaking research, providing information, marketing and distribution for improvement of the livestock industry.

Our Vision

A globally recognized institute in the production and supply of high quality and affordable veterinary vaccines and services.

Our Mandate

The Kenya Veterinary Vaccines Production Institute (KEVEVAPI) derives it mandate under the State Corporations Act, Cap 446 of the laws of Kenya through legal notice No. 223 of 4th June, 1990.

Wednesday, 24 September 2014 00:00

Role of KEVEVAPI in Economy

Most of livestock diseases are endemic and pose severe constrains to the livestock industry. They cause economic losses through deaths and decreased production. Some countries like the United States of America and Great Britain have used slaughter and compensation policy in control of Foot and Mouth and New Castle diseases. However, it is a very expensive policy for a developing country like Kenya to undertake. The only affordable alternative is vaccination; hence the more the need for a functional local veterinary vaccines production facility, thus KEVEVAPI, to provide the appropriate vaccines for the country. The Institute has been in existence as a Centre under Kenya Agricultural Research Institute (KARI) and has been producing vaccines to meet the local demand. This has enhanced the livestock industry to contribute to the GDP.

Page 2 of 3

Find Us Here

Kenya Veterinary Vaccines Production Institute

P.O. BOX 53260 00200 
Head Office, Embakasi off Enterprise Road, Road A,
NAIROBI, KENYA

Job Application Login

Join Our Mailing List